Locations:
Search IconSearch

Two New Inpatient Rehab Hospitals Broaden a Growing Regional Footprint

60-bed facilities have opened east and south of Cleveland

17-NEU-4263-Rehab-Hosp-650×450

Cleveland Clinic just opened two new inpatient rehabilitation hospitals to be operated in a joint venture with rehabilitation services provider Select Medical Corp. The first of the new facilities, located east of Cleveland in Beachwood, Ohio, opened in early October 2017. The other facility, south of Cleveland in Bath, Ohio, opened in early November. Each hospital has 60 beds.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The photo above shows two leaders of the Beachwood facility — Cleveland Clinic Rehabilitation Hospital, Beachwood — outside the new building. On the left is the facility’s Chief Executive Office/Market Executive, Dave Richer, and on the right is its Medical Director, Patrick Shaughnessy, MD.

These two latest hospitals join another new inpatient rehab hospital operated under the joint venture — opened in Avon, Ohio, west of Cleveland in December 2015 — to expand a growing regional inpatient rehabilitation footprint complementing the services offered at Cleveland Clinic’s main campus hospital.

Early results out of the new rehab hospital in Avon bode well for the joint venture with Select. In just its first year of operation (2016), the Avon facility exceeded the joint venture benchmark for patient satisfaction scores and surpassed the weighted national average in patients discharged home. This was accomplished despite a case mix index higher the national 50th percentile.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad